CONSTANT THERAPEUTICS
Constant Therapeutics is a biopharmaceutical company that develops drugs and therapies, with clinical trials for a range of diseases.
CONSTANT THERAPEUTICS
Social Links:
Industry:
Biotechnology Clinical Trials Health Care Medical Pharmaceutical
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.constanttherapeutics.com
Total Employee:
1+
Status:
Active
Contact:
+1-617-245-0289
Email Addresses:
[email protected]
Similar Organizations
PARAMEDICAL SERVICE OF AMERICA INC
Paramedical Service of America Inc has the skill and reach to help make clinical trials seamless and professional.
Current Employees Featured
Founder
Official Site Inspections
http://www.constanttherapeutics.com Semrush global rank: 6.06 M Semrush visits lastest month: 1.34 K
- Host name: 198.49.23.144
- IP address: 198.49.23.144
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "Constant Therapeutics"
Constant Therapeutics - Crunchbase Company Profile & Funding
Organization. Constant Therapeutics . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. About. ... Contact Email [email protected]; …See details»
Constant Therapeutics LLC - Drug pipelines, Patents, Clinical
Www.constanttherapeutics.com. Private Company | Massachusetts, United States | < 10 | www.constanttherapeutics.com. Last update 01 Nov 2024. Overview. Pipeline. Deal. …See details»
CONSTANT THERAPEUTICS LLC - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for CONSTANT THERAPEUTICS LLC of Boston, MA. Get the latest business insights from Dun & Bradstreet.See details»
Constant Therapeutics Company Profile | Management and
Www.constanttherapeutics.com Constant Therapeutics Profile and History Constant Therapeutics LLC is a private biopharmaceutical company developing peptide and small molecule drugs …See details»
Constant Therapeutics - Craft
Constant Therapeutics is a company developing proprietary peptides for the treatment of CNS and rare disorders. Its lead clinical programs are in stroke recovery, epidermolysis bullosa, …See details»
Constant Therapeutics Company Profile -Sales, Contacts, …
Constant Therapeutics is in the Commercial Physical Research industry within the Engineering, Accounting, Research, and Management Services sector and has been in business for …See details»
Constant Therapeutics - Overview, News & Similar companies
Feb 23, 2021 Constant Therapeutics contact info: Phone number: (617) 245-0289 Website: www.constanttherapeutics.com What does Constant Therapeutics do? Constant Therapeutics …See details»
Constant Therapeutics - LinkedIn
Constant Therapeutics | 187 followers on LinkedIn. Constant is a clinical stage company developing Mas/MrgD receptor agonists for treatment of CNS and rare disorders. | Constant's …See details»
Constant Therapeutics - VentureRadar
Constant Therapeutics VentureRadar profile. Find out more about Constant Therapeutics, DNA, RNA and Peptide Therapies.See details»
CONSTANT THERAPEUTICS LLC overview - Find and update …
CONSTANT THERAPEUTICS LLC - Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, charges, business …See details»
Constant Therapeutics, LLC | Pharmaceutical - BioUtah
Constant Therapeutics is a clinical stage company developing proprietary peptides for treatment of CNS and rare disorders. It’s lead clinical programs are in stroke recovery and epidermolysis …See details»
Constant Therapeutics Announces First Patient Dosed in Phase 2 …
Jan 9, 2024 [email protected] +1-617-245-0289. SOURCE Constant Therapeutics. Recent News. BioUtah Award Winners and Utah Rare Disease Advisory Council …See details»
Constant Therapeutics Announces First Patient Dosed in Phase 2 …
Mar 3, 2024 [email protected] +1-617-245-0289. SOURCE Constant Therapeutics. Recent News. Seek Labs Announces Partnership with Cerbrec to Accelerate …See details»
Constant Therapeutics Announces First Patient Dosed in Phase 2 …
Mar 4, 2024 Constant Therapeutics LLC, a biopharmaceutical company focused on the development of treatments impacting the Alternative Renin-Angiotensin System, today …See details»
Constant Therapeutics TXA127 For COVID-19 To Enter NIH …
May 12, 2021 For more information on Constant Therapeutics, please visit our website at www.constanttherapeutics.com. CONTACT: Rick Franklin 617-245-0289 [email protected]See details»
Constant Therapeutics Announces First Patient Dosed in Phase 2 …
BOSTON, March 4, 2024 /PRNewswire/ -- Constant Therapeutics LLC, a biopharmaceutical company focused on the development of treatments impacting the Alternative Renin …See details»
Constant Therapeutics TXA127 For COVID-19 To Enter ... - Markets …
BOSTON, May 12, 2021 /PRNewswire/ -- As the focus on the COVID-19 pandemic shifts to raising the number of vaccinated people around the world, U.S. researchers, funded by the …See details»
Constant Therapeutics Announces First Patient Dosed in Phase 2 …
BOSTON, Jan. 9, 2024 /PRNewswire/ -- Constant Therapeutics LLC, a biopharmaceutical company focused on the development of treatments impacting the Alternative Renin …See details»
Constant Therapeutics' TXA127 to be tested in Multiple Clinical …
Jul 8, 2020 For more information on Constant Therapeutics, please visit our website at www.constanttherapeutics.com. Contact: [email protected] +1-617-245-0289 . SOURCE …See details»
Constant Therapeutics' TXA127 to be tested in Multiple ... - BioSpace
Jul 8, 2020 This protective pathway involves the enzyme ACE2, its principal product, the peptide angiotensin-(1-7), and the peptide's target, the Mas receptor. Constant's lead drug candidate …See details»